The Value of KOL Identification for Pharma & Biotech Teams
Traditional KOL lists focus on simple attributes like publication counts or conference appearances, but they rarely tell you which experts truly influence behaviour, access and decision-making in your markets. KOL identification with VML Health is designed to move beyond static lists, giving pharma and biotech teams a clearer, more strategic view of who matters, why they matter and how they can support your brand and evidence plans.

Why KOL Identification Matters in Pharma
KOL identification is the foundation of every effective medical and commercial strategy, from launch planning through late lifecycle optimisation. When you know which experts are genuinely shaping guidelines, trial design, adoption and peer opinion, you can target your limited time and budget where they will have the greatest impact.
Accurate KOL identification also reduces risk by ensuring that expert engagement is transparent, defensible and aligned with your scientific story and compliance requirements.

What Effective KOL Identification Delivers
Effective KOL identification gives your teams far more than a list of names. It delivers structured, prioritised insight into who your experts are, what they do, how they influence others and where they sit within the wider stakeholder ecosystem.
This allows you to design stronger advisory boards, more targeted education, better evidence-generation programmes and more relevant omnichannel engagement, all anchored to the right people in the right places.

The Risks of Getting KOL Identification Wrong
Relying on incomplete databases, anecdotal lists or historical relationships can leave big gaps in your expert strategy. You risk over-indexing on a few familiar names while missing regional influencers, rising stars, digital opinion leaders and catalysts of change who are actually driving day-to-day practice.
Poor KOL identification can also lead to misaligned investments, duplicated efforts across teams and engagement plans that fail to land with the people who truly shape behaviour.

How VML Health Adds Value to KOL Identification
VML Health combines multi-source data, structured research frameworks and deep therapy-area experience to deliver KOL identification that your organisation can trust and act on. Our work is grounded in clear criteria, transparent methods and collaborative scoping, so outputs are tailored to your strategy, timelines and internal ways of working.
Because we also specialise in KOL mapping and engagement, every identification project is designed to connect naturally into network analysis, segmentation and real-world activation. Link to kolmapping.com.
From KOL Identification to Actionable Strategy
The value of KOL identification is ultimately measured by what it enables your teams to do differently. With a clear, prioritised view of your expert landscape, you can plan evidence and engagement with confidence, align medical and commercial activities around shared expert segments and adapt quickly as new voices emerge.
Speak to us about how we can
help you identify the people who can most strongly impact the success of your brand and your scientific story.
